Literature DB >> 22890915

Association between polymorphisms of eNOS and GPx-1 genes, activity of free-radical processes and in-stent restenosis.

Yu A Shuvalova1, A I Kaminnyi, A N Meshkov, R O Shirokov, A N Samko.   

Abstract

Our aim was to examine correlations between polymorphisms in five antioxidant enzymes genes, activity of free-radical processes, and the risk of restenosis after coronary artery stenting with bare metal stents (BMS). A total of 101 male patients who underwent intracoronary stenting using BMS and coronary angiography follow-up of 6 months were enrolled in: group with in-stent restenosis (n = 44) and without restenosis (n = 57). The content of lipoperoxides and malondialdehyde (MDA) in Low-density lipoprotein (LDL), activity of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) in erythrocytes, and genotypes polymorphisms of the CAT gene (-262C/T), paraoxonase-1 (PON-1) gene (163T/A and 575A/G), endothelial nitric oxide synthase (eNOS) gene (298G/T (rs#1799983) and -786T/C), GPx-1 gene (599C/T (rs#1050450)), and glutathione-S-transferase (GSTP) gene (313A/G) were determined. In carriers of the minor allele of 599C/T polymorphism of the GPx-1 gene, activity of GPx in erythrocytes was lower by 17 % than in wild allele homozygotes, while the content of lipoperoxides in LDL was higher by 74 %. T-allele of 599C/T polymorphism of the GPx-1 gene (OR = 2.9; 95 % CI: 1.23-6.82) and T-allele of 298G/T polymorphism of the eNOS gene (OR = 2.79; 95 % CI: 1.17-6.66) were associated with the risk of in-stent restenosis. Minor alleles of polymorphisms 298G/T of the eNOS gene and 599C/T of the GPx-1 gene are associated with an increased risk of in-stent restenosis. Minor allele of the GPx-1 gene 599C/T polymorphism leads to a decrease of the GPx activity and increase of the activity of free-radical processes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890915     DOI: 10.1007/s11010-012-1419-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

Review 1.  Coronary in-stent restenosis - predictors, treatment and prevention.

Authors:  R Hoffmann; G S Mintz
Journal:  Eur Heart J       Date:  2000-11       Impact factor: 29.983

Review 2.  Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS.

Authors:  Kathy K Griendling; Garret A FitzGerald
Journal:  Circulation       Date:  2003-10-21       Impact factor: 29.690

3.  The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis.

Authors:  A H Gomma; M A Elrayess; C J Knight; E Hawe; K M Fox; S E Humphries
Journal:  Eur Heart J       Date:  2002-12       Impact factor: 29.983

4.  Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study.

Authors:  Gitte Ravn-Haren; Anja Olsen; Anne Tjønneland; Lars O Dragsted; Bjørn A Nexø; Håkan Wallin; Kim Overvad; Ole Raaschou-Nielsen; Ulla Vogel
Journal:  Carcinogenesis       Date:  2005-11-14       Impact factor: 4.944

5.  PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement.

Authors:  A Kastrati; W Koch; M Gawaz; J Mehilli; C Böttiger; K Schömig; N von Beckerath; A Schömig
Journal:  J Am Coll Cardiol       Date:  2000-07       Impact factor: 24.094

Review 6.  Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis.

Authors:  L C Azevedo; M A Pedro; L C Souza; H P de Souza; M Janiszewski; P L da Luz; F R Laurindo
Journal:  Cardiovasc Res       Date:  2000-08-18       Impact factor: 10.787

7.  Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study.

Authors:  Renate Schnabel; Karl J Lackner; Hans J Rupprecht; Christine Espinola-Klein; Michael Torzewski; Edith Lubos; Christoph Bickel; François Cambien; Laurence Tiret; Thomas Münzel; Stefan Blankenberg
Journal:  J Am Coll Cardiol       Date:  2005-04-25       Impact factor: 24.094

8.  Risk of restenosis and health status outcomes for patients undergoing percutaneous coronary intervention versus coronary artery bypass graft surgery.

Authors:  John A Spertus; Ravi Nerella; Richard Kettlekamp; John House; Steve Marso; A Michael Borkon; John S Rumsfeld
Journal:  Circulation       Date:  2005-02-07       Impact factor: 29.690

9.  Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in japanese type 2 diabetic patients.

Authors:  Tohru Hamanishi; Hiroto Furuta; Hisako Kato; Asako Doi; Masanori Tamai; Hiroko Shimomura; Setsuya Sakagashira; Masahiro Nishi; Hideyuki Sasaki; Tokio Sanke; Kishio Nanjo
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

10.  Polymorphisms in the promoter region of catalase gene and essential hypertension.

Authors:  Xiao Feng Zhou; Jing Cui; Anita L DeStefano; Irmarie Chazaro; Lindsay A Farrer; Athanasios J Manolis; Haralambos Gavras; Clinton T Baldwin
Journal:  Dis Markers       Date:  2005       Impact factor: 3.434

View more
  12 in total

1.  Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population.

Authors:  Elena V Zholdybayeva; Yerkebulan A Talzhanov; Akbota M Aitkulova; Pavel V Tarlykov; Gulmira N Kulmambetova; Aisha N Iskakova; Aliya U Dzholdasbekova; Olga A Visternichan; Dana Zh Taizhanova; Yerlan M Ramanculov
Journal:  Hum Genomics       Date:  2016-06-08       Impact factor: 4.639

2.  Allele-specific interaction between glutathione peroxidase 1 and manganese superoxide dismutase affects the levels of Bcl-2, Sirt3 and E-cadherin.

Authors:  Dede N Ekoue; Soumen Bera; Emmanuel Ansong; Peter C Hart; Sofia Zaichick; Frederick E Domann; Marcelo G Bonini; Alan M Diamond
Journal:  Free Radic Res       Date:  2017-07-04

Review 3.  The role of glutathione peroxidase-1 in health and disease.

Authors:  Diane E Handy; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2022-06-09       Impact factor: 8.101

4.  Association between Oxidative Burden and Restenosis: A Case-Control Study.

Authors:  Shiva Ganjali; Atena Mansouri; Mitra Abbasifard; Seyed Adel Moallem; Zahra Tayarani-Najaran; Amirhossein Sahebkar
Journal:  Oxid Med Cell Longev       Date:  2022-06-28       Impact factor: 7.310

5.  Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis.

Authors:  Zhigang Zhao; Xingang Li; Shusen Sun; Shenghui Mei; Ning Ma; Zhongrong Miao; Ming Zhao; Shiqi Peng
Journal:  Eur J Clin Pharmacol       Date:  2016-07-23       Impact factor: 2.953

Review 6.  Genetics of coronary artery disease and myocardial infarction.

Authors:  Xuming Dai; Szymon Wiernek; James P Evans; Marschall S Runge
Journal:  World J Cardiol       Date:  2016-01-26

7.  Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent.

Authors:  Wen-Ping Zeng; Rui Zhang; Ran Li; Jin-Fang Luo; Xiao-Feng Hu
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

8.  Association of glutathione peroxidase-1 (GPx-1) rs1050450 Pro198Leu and Pro197Leu polymorphisms with cardiovascular risk: a meta-analysis of observational studies.

Authors:  Jun-Xia Zhang; Zhi-Mei Wang; Jun-Jie Zhang; Lin-Lin Zhu; Xiao-Fei Gao; Shao-Liang Chen
Journal:  J Geriatr Cardiol       Date:  2014-06       Impact factor: 3.327

9.  The rs1803274 polymorphism of the BCHE gene is associated with an increased risk of coronary in-stent restenosis.

Authors:  L Pleva; P Kovarova; L Faldynova; P Plevova; S Hilscherova; J Zapletalova; P Kusnierova; P Kukla
Journal:  BMC Cardiovasc Disord       Date:  2015-10-24       Impact factor: 2.298

10.  Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience.

Authors:  Elizabeth M J Lee; Karen Xu; Emma Mosbrook; Amanda Links; Jessica Guzman; David R Adams; Elise Flynn; Elise Valkanas; Camillo Toro; Cynthia J Tifft; Cornelius F Boerkoel; William A Gahl; Murat Sincan
Journal:  Genet Med       Date:  2016-06-02       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.